Pharmacy Innovations: Drug Recall
Recall #D-0227-2023 · 12/22/2022
Class II: Risk
Recall Details
- Recall Number
- D-0227-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Pharmacy Innovations
- Status
- Terminated
- Date Initiated
- 12/22/2022
- Location
- Erie, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- N/A
Reason for Recall
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Product Description
PE1/PAPAV/ATROP/CHLOPROM** 7MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/ATROP/CHLORPROM 100MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/ATROP/CHLORPROM 15MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/ATROP/CHLORPROM 30MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/ATROP/CHLORPROM** 7MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Distribution Pattern
Nationwide in the USA
Other Recalls by Pharmacy Innovations
- Class II: Risk 12/22/2022
- Class II: Risk 12/22/2022
- Class II: Risk 12/22/2022
- Class II: Risk 12/22/2022
- Class II: Risk 12/22/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.